HEMISPHERX BIOPHARMA INC Uncategorized Contracts & Agreements
64 Contracts & Agreements
- Amended and Restated Material Transfer and Research Agreement with Roswell Park Cancer Institute Corporation (Filed With SEC on September 29, 2023)
- Material Transfer and Research Agreement, dated as of May 22, 2023, by and between AIM ImmunoTech Inc. and Japanese National Institute of Infectious Disease. (portions of this... (Filed With SEC on May 30, 2023)
- Unrestricted Grant Agreement with Erasmus University Medical Center (Filed With SEC on April 7, 2023)
- March 1, 2023 Extension Agreement with Foresite Advisors LLC (Filed With SEC on March 31, 2023)
- January 13, 2023 Co-ordination Agreement with Erasmus University Medical Center Rotterdam and AstraZeneca BV (portions of this agreement have been redacted in compliance with... (Filed With SEC on March 31, 2023)
- January 13, 2023 Study Support Agreement with Erasmus University Medical Center Rotterdam (portions of this agreement have been redacted in compliance with Regulation S-K Item... (Filed With SEC on March 31, 2023)
- October 21, 2022 Material Transfer and Research Agreement with University of Pittsburgh (portions of this agreement have been redacted in compliance with Regulation S-K Item... (Filed With SEC on November 14, 2022)
- October 11, 2022 Material Transfer and Research Agreement with University of Pittsburgh (portions of this agreement have been redacted in compliance with Regulation S-K Item... (Filed With SEC on November 14, 2022)
- June 13, 2022 Amarex Work Order (portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10)) (Filed With SEC on June 17, 2022)
- April 7, 2022 Amarex Work Order (portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10)) (Filed With SEC on April 12, 2022)
- April 1, 2021 extension of April 1, 2020 Material Transfer and Research Agreement with Shenzhen Smoore Technology Limited (Filed With SEC on August 16, 2021)
- May 21, 2021 extension of April 1, 2020 Material Transfer and Research Agreement with Shenzhen Smoore Technology Limited (Filed With SEC on August 16, 2021)
- Material Transfer And Research Agreement with the University of Cagliari Dipartimento di Scienze della Vita e dellAmbiente executed on April 5, 2021 (Portions of this Agreement... (Filed With SEC on May 17, 2021)
- May 1, 2021 extension of April 1, 2020 Material Transfer and Research Agreement with Shenzhen Smoore Technology Limited (Filed With SEC on May 17, 2021)
- Material Transfer and Research agreement with Roswell Park Comprehensive Cancer Center executed on April 14, 2021 (Portions of this Agreement have been redacted in compliance with... (Filed With SEC on May 17, 2021)
- December 30, 2020 Amendment to Project Work Order with Amarex Clinical Research LLC. (Portions of this Agreement have been redacted in compliance with Regulation S-K Item... (Filed With SEC on March 31, 2021)
- November 29, 2020, Material Transfer and Research Agreement with Leyden Laboratories, B.V. (Portions of this Agreement have been redacted in compliance with Regulation S-K Item... (Filed With SEC on March 31, 2021)
- January 11, 2021 Sponsor Agreement with Centre for Human Drug Research. (Portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10)) (Filed With SEC on March 31, 2021)
- August 6, 2020, Project Work Order with Amarex Clinical Research LLC. (Portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10)) (Filed With SEC on August 14, 2020)
- July 6, 2020, Clinical Trial Agreement with Roswell Park Comprehensive Cancer Center. (Portions of this Agreement have been redacted in compliance with Regulation S-K Item... (Filed With SEC on August 14, 2020)
- July 1, 2020, Material Transfer and Research Agreement with the Japanese National Institute of Infectious Diseases and Shionogi & Co., Ltd. (Portions of this Agreement have been... (Filed With SEC on August 14, 2020)
- June 1, 2020, Material Transfer and Research Agreement with the University of Rochester. (Portions of this Agreement have been redacted in compliance with Regulation S-K Item... (Filed With SEC on August 14, 2020)
- April 1, 2020 Material Transfer and Research Agreement with Shenzhen Smoore Technology Limited (Filed With SEC on April 6, 2020)
- Amendment to 2017 Material Transfer and Research Agreement with Roswell Park Cancer Institute (Filed With SEC on March 26, 2020)
- Form of Agreement between the Company and the Warrantholders (Filed With SEC on May 2, 2019)
- Form of Dealer - Manager Agreement (Filed With SEC on February 6, 2019)
- October 9, 2018, Restated Bill of Sale for the Restated First Amendment and Sale Agreement (Filed With SEC on November 14, 2018)
- October 9, 2018, Clinical Trial Agreement with Roswell Park Comprehensive Cancer Center (Filed With SEC on November 14, 2018)
- March 26, 2018 Amendment No. 4 to Amended and Restated Early Access Agreement with Impatients N.V (Filed With SEC on March 30, 2018)
- February 14, 2018 Amendment No. 3 to Amended and Restated Early Access Agreement with Impatients N.V (Filed With SEC on March 30, 2018)
- June 28, 2017 Amendment No. 2 to Amended and Restated Early Access Agreement with Impatients N.V (Filed With SEC on March 30, 2018)
- December 13, 2016 Amendment No. 1 to Amended and Restated Early Access Agreement with Impatients N.V (Filed With SEC on March 30, 2018)
- Engagement Letter, dated as of March 21, 2018 by and between Hemispherx Biopharma, Inc. and Ascendiant Capital Markets LLC (Filed With SEC on March 22, 2018)
- AnnexA (Filed With SEC on June 1, 2017)
- PROMISSORYNOTE (Filed With SEC on May 15, 2017)
- AMENDEDAND RESTATED EARLY ACCESS AGREEMENT (Filed With SEC on May 8, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on February 3, 2017)
- AMENDED AND RESTATED EARLY ACCESS AGREEMENT (Filed With SEC on January 17, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on September 1, 2016)
- ********************* (Filed With SEC on September 1, 2016)
